70 Microbiome Companies - Research & Therapeutic
Order by: Company Name - Location
 |
USA - BPG | This is a Premium Listing. Having your company stand out will increase referrals, usually 2x or more. Try it for a month. |
 Nubiyota |
- | Microbiome therapeutics platform |
| Microbiome Insights |
BC - Vancouver | Microbiome Analysis and Research |
| A-Mansia Biotech |
Belgium - Mont-Saint-Guibert | Microbiome Therapies |
| Actym Therapeutics |
CA - Berkeley | Microbial-based immunotherapy platform |
| SciBac |
CA - Burlingame | Live Microbial Therapeutics |
| Evolve BioSystems |
CA - Davis | Probiotic Bacteria |
| Metagenomi |
CA - Emeryville | Gene-Edited Microbial Treatments |
| Pareto Bio |
CA - La Jolla | Microbial therapies to prevent and treat human disease and allergies |
| Osel |
CA - Mountain View | Live Organisms as Treatments |
| Siolta Therapeutics |
CA - San Carlos | Gut Microbiome Modification |
| Bloom Science |
CA - San Diego | Microbiota-Based Drug Discovery |
| Naked Biome |
CA - San Francisco | Microbiome-discovery |
| Federation Bio |
CA - South SF | Design, discover, and develop robust communities of microbes |
| Novome Biotechnologies |
CA - South SF | Gut Microbiome-Derived Cell Therapies for Chronic Diseases |
| Second Genome |
CA - South SF | Microbiome modulators |
| Forte Biosciences |
CA - Torrance | Atopic Dermatitis Treatment |
| BioPlx |
CO - Boulder | Non-antibiotic methods for the control of infectious disease |
| Azitra |
CT - Farmington | Microbiome Skin Treatments |
| Artizan Biosciences |
CT - New Haven | Microbiota-targeted therapies |
| SNIPR Biome |
Denmark - Copenhagen | CRISPR for microbiome management |
| Ysopia Bioscience |
France - Bordeaux | Gut-microbiome-based therapies |
| Exeliom Biosciences |
France - Dijon | Gut microbiome modifiers |
| Biocodex |
France - Gentilly | Microbiota Treatments |
| Vaiomer |
France - LABEGE | Microbial Characterization |
| MaaT Pharma |
France - Lyon | Microbiome Correction |
| DA VOLTERRA |
France - Paris | Microbiota Protection |
| Eligo Bioscience |
France - Paris | Protein-based nanodelivery vectors |
| Enterome |
France - Paris | Microbiome-related diseases, diagnostics |
| Biome360 |
GA - Alpharetta | Consumer Gut Microbiome Analysis |
| BiomeSense |
IL - Chicago | Biosensor & cloud-based software platform for gut microbiome analysis |
| Scioto Biosciences |
IN - Indianapolis | Delivery of microbiome therapeutics |
| BiomX |
Israel - Ness Ziona | Microbiome-based Therapeutics |
| Genome & Company |
Korea - Gyeonggido | Microbiome, Antibody Therapies |
| GI Innovation |
Korea - Seoul | Microbiome combination drug development |
| Kobiolabs |
Korea - Seoul | Microbiome Therapeutics |
| BioLeaders |
Korea - Yongin | Mucosal Immunity Medicine |
| DeepBiome Therapeutics |
MA - Allston | Microbiome Drug Discovery |
| DermBiont |
MA - Boston | Topical Bacterial Products |
| GRO Biosciences |
MA - Boston | Genetically altered bacteria for drug improvement |
| AOBiome |
MA - Cambridge | Bacterial skin therapy |
| Enterome |
MA - Cambridge | Microbiome-related diseases, diagnostics |
| Holobiome |
MA - Cambridge | Microbiome Therapeutics Targeting Nervous System |
| LUCA Biologics |
MA - Cambridge | Treatment Targeting Vaginal Microbiome |
| Seres Therapeutics |
MA - Cambridge | Microbial drugs to counteract antibiotic side effects |
| Solarea Bio |
MA - Cambridge | Microbiome Treatments |
| Vedanta Biosciences |
MA - Cambridge | Therapies that modulate pathways of interaction between the human microbiome and the host immune system |
| Artugen Therapeutics |
MA - Concord | Live Bacterial Treatments |
| Kaleido Biosciences |
MA - Lexington | Compounds Designed for Microbiome Targets |
| Finch Therapeutics |
MA - Somerville | Microbiological Therapy |
| Axial Therapeutics |
MA - Waltham | Neurology-Microbiome research |
| Diversigen |
MN - New Brighton | Microbiome Analysis |
| Rebiotix |
MN - Roseville | Microbiota Restoration Therapy |
| Symberix |
NC - Durham | Small molecules that act upon human microbiome |
| Locus Biosciences |
NC - Morrisville | CRISP-engineered Bacteriophage Therapeutics |
| Caelus Health |
Netherlands - Amsterdam | Microbiome therapeutics for type 2 diabetes in people w/ metabolic syndrome |
| Bio-Me |
Norway - Oslo | Microbiome Profiling |
| MedBiome |
ON - Ottawa | Screening compounds for gut microbiome impact |
| SFA Therapeutics |
PA - Jenkintown | Microbiome-derived metabolites as drugs |
| Microviable Therapeutics |
Spain - Gijon | Intestinal Microbiota Isolation Kit |
| Infant Bacterial Therapeutics |
Sweden - Stockholm | Premature Infant Treatments |
| MetaboGen |
Sweden - Stockholm | Therapeutics and Probiotics |
| Aurealis Therapeutics |
Switzerland - Basel | Transdermal |
| T3 Pharmaceuticals |
Switzerland - Basel | Bacterial Cancer Therapy |
| Redbiotec |
Switzerland - Schlieren | Various Biologic Modalities |
| PharmaBiome |
Switzerland - Zurich | R&D treatment of myelin-related/neurodegenerative disorders by targeting glia |
| OM Pharma |
Swizterland - Meyrin | Microbial derived immunotherapeutic products |
| Diversigen |
TX - Houston | Microbiome Analysis |
| EnteroBiotix |
UK - Aberdeen | Fecal microbiota transplantation |
| Microbiotica |
UK - Cambridge | Gut Bacteria Phenotype to Biomarker/Therapeutics |
| Microbiotica |
UK - Cambridge | Live Bacterial Therapeutics |
| Juno Bio Ltd. |
UK - London | Vaginal Microbiome Health |
| OptiBiotix |
UK - York | Microbiome Modulator Platform |